drugset / Trial / NCT02465749
Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
Phase 0
Unknown
404 enrolled
Sun Yat-sen University
Guangzhou Jeeyor Medical Research Co.,Ltd. · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collabZhujiang Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the role of continuous oxygen therapy combined with blue light deprivation in prevention and control of retinitis pigmentosa, in order to find a new strategy of treatment for retinitis pigmentosa.
Timeline
- Start
- 2015-05
- Primary completion
- 2025-06
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxygen | Other / unclassified | — | — |
| Background | Compound thrombosis capsule | Unknown | 1.5 g | — |
| Background | Ginkgo biloba | Traditional medicine (herbal / TCM) | 300 mg | — |
| Background | Vitamin AD | Unknown | — | — |
| Background | Vitamin B | Unknown | 10 mg | — |